Published: Dec 14, 2020 SAN FRANCISCO, Dec. 14, 2020 /PRNewswire/ -- Astellas Venture Management (President: Kazunori Maruyama, Ph.D, "AVM"), a wholly-owned venture capital subsidiary of Astellas Pharma Inc. and Mission Bay Capital BioLabs ("MBC BioLabs"), a life-science incubator, today announced Keyhole Therapeutics, Inc. and Jupiter Therapeutics, Inc. as the winners of their " Golden Ticket Competition". Building on the success of the inaugural competition held in 2019, the award supports entrepreneurial scientists and emerging biotechnology start-ups to accelerate early drug d...